These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19766892)

  • 21. Health economic issues in the treatment of drug-resistant serious Gram-positive infections.
    Nathwani D
    J Infect; 2009 Sep; 59 Suppl 1():S40-50. PubMed ID: 19766889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Gram-positive bacteraemia.
    Uçkay I; Harbarth S; Pittet D
    Curr Opin Infect Dis; 2007 Dec; 20(6):561-7. PubMed ID: 17975404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
    Stevens DL
    J Infect; 2009 Sep; 59 Suppl 1():S32-9. PubMed ID: 19766887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of urinary tract infections caused by germs resistant to antibiotics commonly used after renal transplantation.
    Di Cocco P; Orlando G; Mazzotta C; Rizza V; D'Angelo M; Clemente K; Greco S; Famulari A; Pisani F
    Transplant Proc; 2008; 40(6):1881-4. PubMed ID: 18675078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics in the intensive care unit: focus on agents for resistant pathogens.
    Volles DF; Branan TN
    Emerg Med Clin North Am; 2008 Aug; 26(3):813-34, x. PubMed ID: 18655946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD; Jones DG; Sánchez Bruni SF
    Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood isolates epidemiology in a clinical haematology department].
    Elmaataoui A; Elghazouani M; Eric NA; Doghmi K; Mikdame M; Elhamzaoui S; Elouennass M
    Ann Biol Clin (Paris); 2009; 67(3):293-7. PubMed ID: 19411231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic options for CNS infections caused by resistant Gram-positive organisms.
    Peppard WJ; Johnston CJ; Urmanski AM
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):83-99. PubMed ID: 18251666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial pressure and the emergence and spread of multiresistant enterococci.
    Rice LB
    Postgrad Med; 2001 Feb; 109(2 Suppl):22-31. PubMed ID: 19667554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Mitrano JA; Spooner LM; Belliveau P
    Pharmacotherapy; 2009 Sep; 29(9):1103-9. PubMed ID: 19698015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections.
    Sincak CA; Schmidt JM
    Ann Pharmacother; 2009 Jun; 43(6):1107-14. PubMed ID: 19435963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-resistant Enterococcus raffinosus from a decubitus ulcer: a case report.
    Savini V; Manna A; Di Bonaventura G; Catavitello C; Talia M; Balbinot A; Febbo F; D'Antonio D
    Int J Low Extrem Wounds; 2008 Mar; 7(1):36-7. PubMed ID: 18372268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriologic features of surgical site infections following breast surgery.
    Mukhtar RA; Throckmorton AD; Alvarado MD; Ewing CA; Esserman LJ; Chiu C; Hwang ES
    Am J Surg; 2009 Oct; 198(4):529-31. PubMed ID: 19800462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Has the era of untreatable infections arrived?
    Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i29-36. PubMed ID: 19675016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of linezolid in critically ill patients admitted to intensive care units.
    Rodríguez O; Alvarez F; Oltra R; Cereijo E; Latorre MM; Martínez H;
    Rev Esp Quimioter; 2009 Jun; 22(2):68-75. PubMed ID: 19554485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.